1. Pink Sheet
  2. >>Geography
  3. >>Europe

Clinical Trial Transparency To Move Up A Notch In UK

HRA To Build Sanctions Into Its Study Approvals Process

 
• By Vibha Sharma

The UK Health Research Authority has adopted a new strategy to give more teeth to its statutory objective of driving improvements in research transparency.

Clinical trials
HRA Plans To Measure Transparency Performance Of Individual Sponsors • Source: Shutterstock

The Health Research Authority has unveiled its much-awaited strategy on how it plans to improve clinical trial transparency in the UK with provisions that will introduce “fair consequences for those who don’t take transparency seriously.”

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United Kingdom

More from Europe

Non-Submissions To England’s NICE Surge Across All Disease Areas

 
• By Leela Barham

Blood cancer therapies were most proportionately impacted by the failure of pharmaceutical companies to submit evidence on their cancer therapies to England’s health technology appraisal body, shows analysis by the Pink Sheet.

UK Mandates Unmodified Standardized Contracts To Speed Clinical Trial Set-Up

 
• By Vibha Sharma

The policy expectation that the model clinical trial agreements are used without modification is in line requests from industry and the NHS/HSC.

New EU Filings

 
• By Neena Brizmohun

Plozasiran, Arrowhead Pharmaceuticals' treatment for familial chylomicronemia syndrome, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.